共 123 条
[1]
Cai L(2001)Oxidative stress and diabetic cardiomyopathy: a brief review Cardiovasc Toxicol 1 181-193
[2]
Kang YJ(2009)Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials Nat Rev Drug Discov 8 417-429
[3]
Calcutt NA(2004)Hyperglycemia-induced oxidative stress in diabetic complications Histochem Cell Biol 122 333-338
[4]
Cooper ME(2011)New perspectives on diabetic vascular complications: the loss of endogenous protective factors induced by hyperglycemia Diabetes Metab J 35 8-11
[5]
Kern TS(2012)The role of oxidative stress and antioxidants in diabetic complications Sultan Qaboos Univ Med J 12 5-18
[6]
Schmidt AM(2007)Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications Curr Med Chem 14 2193-2203
[7]
King GL(2011)The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation Curr Opin Clin Nutr Metab Care 14 41-48
[8]
Loeken MR(2003)Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression J Biol Chem 278 21592-21600
[9]
Jeong IK(2012)Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge Oxid Med Cell Longev 2012 132931-2684
[10]
King GL(2011)Nrf2 activators as attractive therapeutics for diabetic nephropathy Diabetes 60 2683-979